Egypt

The government has set a bold target: by 2030, Egypt will manufacture 140 million human vaccine doses per year.

The initiative recognizes that pharmacists serve as critical figures in healthcare, often representing the first and most accessible point of contact for millions of Egyptians seeking guidance on everyday health concerns.

The facility will include hospitals with a total of 500 beds, a medical faculty designed to educate approximately 5,000 students, and a dedicated research and training centre.

The meeting represents part of the Egyptian Drug Authority’s ongoing efforts to engage with leading international pharmaceutical companies and promote strategic partnerships that support industry development.

The ministry plans to enable electronic information exchange between facilities, which will streamline medical services and reduce administrative burdens on both healthcare providers and patients seeking treatment.

The network will create a nationwide digital infrastructure that enhances diagnostic accuracy while supporting more effective treatment planning for patients throughout Egypt.

The programme will start with a pilot phase at the Nasser Institute Hospital in Cairo, serving as the testing ground for Egypt’s first robotic surgical system in the public sector.

Egypt currently runs 175 stroke units, comprising 113 primary facilities and 62 comprehensive centers.

As part of AAIB’s corporate social responsibility efforts, the system draws on cutting-edge global oncology technology.

The procedures took place at Al-Nasr Specialised Hospital in Port Said, representing a major advancement in accessible cardiac care for Egyptian citizens.